U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07841080) titled 'Percutaneous Stellate Ganglion Block as First Line Treatment in Patients With Electrical Storm: the STAR 2 Study' on Sept. 15.
Brief Summary: Electrical storm (ES) is a life-threatening condition characterized by recurrent episodes of ventricular tachycardia (VT) or ventricular fibrillation (VF) requiring anti-tachycardia pacing or defibrillator shocks. Despite advances in management, ES remains associated with high morbidity and mortality, and current pharmacological options are often insufficient or slow-acting.
The STAR 2 study is a multicentre, randomized, open-label, adaptive superiority trial designed to evaluate whether per...